PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,601 | +6.6% | 90,564 | -13.7% | 0.00% | – |
| Q2 2023 | $120,682 | +53.3% | 104,942 | +41.3% | 0.00% | – |
| Q1 2023 | $78,722 | -16.2% | 74,265 | +20.1% | 0.00% | – |
| Q4 2022 | $93,992 | -70.3% | 61,837 | -58.6% | 0.00% | – |
| Q3 2022 | $317,000 | +58.5% | 149,306 | -0.3% | 0.00% | – |
| Q2 2022 | $200,000 | -15.6% | 149,693 | +33.3% | 0.00% | – |
| Q1 2022 | $237,000 | -61.3% | 112,267 | -32.1% | 0.00% | – |
| Q4 2021 | $613,000 | -74.5% | 165,353 | -65.7% | 0.00% | -100.0% |
| Q3 2021 | $2,404,000 | -5.8% | 481,777 | +23.0% | 0.00% | 0.0% |
| Q2 2021 | $2,553,000 | +4.8% | 391,627 | +10.8% | 0.00% | 0.0% |
| Q1 2021 | $2,436,000 | +0.7% | 353,503 | +49.2% | 0.00% | 0.0% |
| Q4 2020 | $2,418,000 | +208.0% | 236,932 | +5.6% | 0.00% | – |
| Q3 2020 | $785,000 | -41.3% | 224,389 | -16.3% | 0.00% | – |
| Q2 2020 | $1,338,000 | +145.5% | 268,233 | +67.7% | 0.00% | – |
| Q1 2020 | $545,000 | – | 159,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |